Palvella Therapeutics Inc (PVLA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
27.43 -0.18 (-0.65%) 03/20/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 27.43 unch (unch) 16:00 ET
for Thu, Mar 20th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 42,810 | 25,902 | 31,418 | 29,323 | 46,279 |
| Gross Profit | 42,810 | 25,902 | 31,418 | 29,323 | 46,279 |
| Operating Expenses | 72,566 | 69,376 | 83,249 | 63,244 | 73,436 |
| Operating Income | -29,756 | -43,474 | -51,831 | -33,921 | -27,157 |
| Other Income | 5,213 | 10,197 | 6,093 | -3,145 | 1,688 |
| Pre-tax Income | -24,543 | -33,277 | -45,738 | -37,066 | -25,469 |
| Income Tax | N/A | N/A | N/A | 164 | N/A |
| Net Income Continuous | -24,543 | -33,277 | -45,738 | -37,230 | -25,469 |
| Net Income | $-24,543 | $-33,277 | $-45,738 | $-37,230 | $-25,469 |
| EPS Basic Total Ops | -21.60 | -36.00 | -56.80 | -54.40 | -44.80 |
| EPS Basic Continuous Ops | -21.80 | -35.89 | -56.69 | -54.67 | -40.25 |
| EPS Diluted Total Ops | -21.60 | -36.00 | -56.80 | -54.40 | -44.80 |
| EPS Diluted Continuous Ops | -21.80 | -35.89 | -56.69 | -54.67 | -40.25 |
| EPS Diluted Before Non-Recurring Items | -9.60 | -36.00 | -56.80 | -54.40 | -44.80 |
| EBITDA(a) | $-27,852 | $-40,704 | $-49,372 | $-31,610 | $-26,525 |